General Information of the Compound
| Compound ID |
CP0109203
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[8-[[2-cyclopropyl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H25F3N2O4
|
||||||||||||||||||
| Molecular Weight |
474.479
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)c1ccc(cc1)N1CC2(CCN(Cc3cc(ccc3C3CC3)C(F)(F)F)CC2)OC1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H25F3N2O4/c26-25(27,28)19-5-8-21(16-1-2-16)18(13-19)14-29-11-9-24(10-12-29)15-30(23(33)34-24)20-6-3-17(4-7-20)22(31)32/h3-8,13,16H,1-2,9-12,14-15H2,(H,31,32)
Show/Hide
|
||||||||||||||||||
| InChIKey |
UNCDRASKFWAOIZ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01196, Somatostatin receptor type 5
Protein ID: PT06443, Somatostatin receptor type 5